Insitro

South San Francisco, CA · Founded 2018 · Biotech · Private

Machine learning platform that integrates biological data to identify and optimize drug candidates

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · insitro.com

Sector
Biotech
Headquarters
South San Francisco, CA
Founded
2018
Latest Form D
$143M, May 2020
Total capital
$143M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$143M
1 Form D · last May 2020
77 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
22
18 pending · first 2024
Rank in peer group#2 of 55

Capital timeline

2020FEDERAL ↑EQUITY ↓Cumulative $143M1st Form D$143M
2020FEDERAL ↑EQUITY ↓Cumulative $143M1st Form D$143M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$143M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 55 peers

Line = median

Biotech · Software

  • Granted patents#2 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Daphne KollerResearcherExecutive Officer, DirectorLinked by 1 patent
  • Duane ValzExecutive OfficerNamed in SEC Form D filings
  • Mary RozenmanExecutive OfficerNamed in SEC Form D filings
  • Robert NelsenDirectorNamed in SEC Form D filings
  • Vijay PandeDirectorNamed in SEC Form D filings

What it has protected

USPTO · 22 granted of 40
Show all 40 patent records
  • NOVICI BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts
  • AERIE PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
  • Gate BioscienceSimilar federal contract value in Biotech · null in contracts
  • Nurix TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • FIVE ELEVEN PHARMA, INC.Similar federal contract value in Biotech · null in contracts
  • Z BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .